Effect of tashinone on nitric oxide synthase in hypertrophic cadiocyte of rats suffered abdominal aorta constriction

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 12, 2008, Pages 1446-1450

  Li, Yong Sheng ^a   Wang, Zhao Hua ^a   Yan, Li ^a   Yong, Yong Quan ^a   Wang, Jin ^a   Liang, Qian Sheng ^a   Zheng, Zhi ^a   Yang, Guang Tian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Genic expression; Hypertrophic myocardium; Nitric oxide synthase; Pressure overload; Protein kinase C; Tanshinone IIA

Indexed keywords

BENZOFURAN DERIVATIVE; HERBACEOUS AGENT; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; TASHINONE IIA;

ABDOMINAL AORTA; ANIMAL; ARTICLE; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; HEART VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; STENOSIS, OCCLUSION AND OBSTRUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, ABDOMINAL; BENZOFURANS; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART VENTRICLES; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; RATS; RNA, MESSENGER;

EID: 50249178084     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chinese source
2. Bubikat A, De Windt L J, Zetsche B, et al. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice [J]. J Biol Chem, 2005,280(22):21594.
3. Takahashi K, Ouyang X, Komatsu K, et al. Sodium tanshinone II A sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells[J]. Biochem Pharmacol, 2002,15(4):745.
4. Chinese source
5. Cheng T H, Shih N L, Chen S Y, et al. Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation[J]. Mol Pharmacol, 2005,68(4):1183.
6. Chinese source
7. Shimamura S, Endo H, Kutsuna H, et al. Effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with pressure-overload heart[J]. J Vet Med Sci, 2006,68(3):213.
8. Massin P B, Balligand J L. Modulation of cardiac contraction relaxatio and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice[J]. J Physiol, 2003,546:63.
9. Ozaki M, Kawashima S, Yamashita T, et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion[J]. Circ J, 2002,66:851.
10. Zanfolin M, Faro R, Araujo E G, et al. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats[J]. J Cardiovasc Pharmacol, 2006,47(3):391.
11. Chinese source
12. Yang L, Zou X, Liang Q, et al. Sodium tanshinone II A sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway[J]. Exp Mol Med, 2007,39(1):65.